Technical Analysis for PAND - Pandion Therapeutics Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Down |
| Historical PAND trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.18% | |
| Calm After Storm | Range Contraction | 0.18% | |
| Narrow Range Bar | Range Contraction | 0.18% | |
| NR7 | Range Contraction | 0.18% | |
| Oversold Stochastic | Weakness | 0.18% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Outside Day | 2 days ago | |
| Down 1% | 2 days ago | |
| Non-ADX 1,2,3,4 Bearish Retracement Entry | 2 days ago | |
| Fell Below Previous Day's Low | 2 days ago | |
| 60 Minute Opening Range Breakdown | 2 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
- Sector: Healthcare
- Industry: Biotechnology
Pandion Therapeutics is developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases. Pandion’s TALON (Therapeutic Autoimmune reguLatOry proteiN) drug design and discovery platform enables the company to create a pipeline of product candidates using immunomodulatory effector modules, with the ability to also combine an effector module with a tissue-targeted tether module in a bifunctional format. Pandion’s lead product candidate, PT101, is currently in a Phase 1a clinical trial.
Medicine Clinical Medicine Immunology Immunotherapy Autoimmune Diseases Autoimmunity Autoimmune Disease Drug Design
Medicine Clinical Medicine Immunology Immunotherapy Autoimmune Diseases Autoimmunity Autoimmune Disease Drug Design
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 27.75 |
| 52 Week Low | 10.52 |
| Average Volume | 141,009 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 14.76 |
| 20-Day Moving Average | 11.42 |
| 10-Day Moving Average | 11.33 |
| Average True Range | 0.96 |
| ADX | 21.24 |
| +DI | 17.67 |
| -DI | 19.46 |
| Chandelier Exit (Long, 3 ATRs ) | 10.86 |
| Chandelier Exit (Short, 3 ATRs ) | 13.39 |
| Upper Bollinger Band | 12.15 |
| Lower Bollinger Band | 10.70 |
| Percent B (%b) | 0.3 |
| BandWidth | 12.68 |
| MACD Line | -0.93 |
| MACD Signal Line | -1.11 |
| MACD Histogram | 0.1751 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 11.49 | ||||
| Resistance 3 (R3) | 11.47 | 11.34 | 11.43 | ||
| Resistance 2 (R2) | 11.34 | 11.24 | 11.35 | 11.41 | |
| Resistance 1 (R1) | 11.23 | 11.19 | 11.17 | 11.25 | 11.39 |
| Pivot Point | 11.10 | 11.10 | 11.06 | 11.11 | 11.10 |
| Support 1 (S1) | 10.99 | 11.00 | 10.93 | 11.01 | 10.87 |
| Support 2 (S2) | 10.86 | 10.95 | 10.87 | 10.85 | |
| Support 3 (S3) | 10.75 | 10.86 | 10.83 | ||
| Support 4 (S4) | 10.77 |
